Use of a standardized web-based tool (WBT) for evaluation of aromatase inhibitor (AI) related bone loss in breast cancer patients (BCP)
2008
20754 Background: ASCO guidelines recommend AI adjuvant therapy in postmenopausal hormone receptor positive BCP. AI treated BCP have a higher rate of osteoporosis (OP); timely diagnosis and treatme...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI